SNY vs. RACE
SNY (Sanofi) and RACE (Ferrari N.V.) are both stocks. SNY operates in Drug Manufacturers - General (Healthcare), while RACE operates in Auto Manufacturers (Consumer Cyclical). Over the past 10 years, SNY returned 5.78%/yr vs 25.24%/yr for RACE. At a 0.31 correlation, their price movements are largely independent.
Performance
SNY vs. RACE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SNY achieves a -3.62% return, which is significantly lower than RACE's -1.73% return. Over the past 10 years, SNY has underperformed RACE with an annualized return of 5.78%, while RACE has yielded a comparatively higher 25.24% annualized return.
SNY
- 1D
- 0.32%
- 1M
- 3.65%
- YTD
- -3.62%
- 6M
- -4.06%
- 1Y
- -5.97%
- 3Y*
- 0.21%
- 5Y*
- 0.40%
- 10Y*
- 5.78%
RACE
- 1D
- -2.93%
- 1M
- 10.50%
- YTD
- -1.73%
- 6M
- -1.08%
- 1Y
- -21.64%
- 3Y*
- 7.34%
- 5Y*
- 12.24%
- 10Y*
- 25.24%
SNY vs. RACE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SNY Sanofi | -3.62% | 4.93% | 1.09% | 6.55% | 0.57% | 7.00% | 0.39% | 20.47% | 6.06% | 9.96% |
RACE Ferrari N.V. | -1.73% | -11.65% | 26.34% | 59.12% | -16.68% | 13.32% | 39.71% | 67.87% | -4.47% | 81.95% |
Correlation
The correlation between SNY and RACE is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.34 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.28 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.30 |
Correlation (All Time) Calculated using the full available price history since Oct 21, 2015 | 0.31 |
Fundamentals
SNY:
$106.57B
RACE:
$62.93B
SNY:
€3.09
RACE:
€8.98
SNY:
12.38
RACE:
34.15
SNY:
1.98
RACE:
7.58
SNY:
1.27
RACE:
13.39
SNY:
€47.35B
RACE:
€7.21B
SNY:
€34.18B
RACE:
€3.72B
SNY:
€12.63B
RACE:
€3.18B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SNY vs. RACE — Risk / Return Rank
SNY
RACE
SNY vs. RACE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Sanofi (SNY) and Ferrari N.V. (RACE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SNY | RACE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.34 | ||
| Sortino ratioReturn per unit of downside risk | +0.47 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 0.90 | +0.06 |
| Calmar ratioReturn relative to maximum drawdown | -0.49 | -0.59 | +0.10 |
| Martin ratioReturn relative to average drawdown | -0.96 | -0.93 | -0.03 |
Loading charts...
Drawdowns
SNY vs. RACE - Drawdown Comparison
The maximum SNY drawdown since its inception was -46.46%, roughly equal to the maximum RACE drawdown of -46.67%. Use the drawdown chart below to compare losses from any high point for SNY and RACE.
Loading charts...
Drawdown Indicators
| SNY | RACE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -46.46% | -46.67% | +0.21% |
Max Drawdown (1Y)Largest decline over 1 year | -16.70% | -39.22% | +22.52% |
Max Drawdown (3Y)Largest decline over 3 years | -23.37% | -39.22% | +15.85% |
Max Drawdown (5Y)Largest decline over 5 years | -33.52% | -39.22% | +5.70% |
Max Drawdown (10Y)Largest decline over 10 years | -33.52% | -39.22% | +5.70% |
Current DrawdownCurrent decline from peak | -17.91% | -29.85% | +11.94% |
Average DrawdownAverage peak-to-trough decline | -12.20% | -11.50% | -0.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.63% | 25.02% | -16.39% |
Volatility
SNY vs. RACE - Volatility Comparison
The current volatility for Sanofi (SNY) is 8.05%, while Ferrari N.V. (RACE) has a volatility of 12.55%. This indicates that SNY experiences smaller price fluctuations and is considered to be less risky than RACE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SNY | RACE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.05% | 12.55% | -4.50% |
Volatility (6M)Calculated over the trailing 6-month period | 15.99% | 24.53% | -8.54% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.71% | 35.36% | -9.65% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.82% | 29.55% | -4.73% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.47% | 29.55% | -6.08% |
Dividends
SNY vs. RACE - Dividend Comparison
SNY's dividend yield for the trailing twelve months is around 5.47%, more than RACE's 2.40% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RACE Ferrari N.V. | 2.40% | 1.85% | 0.61% | 0.59% | 0.69% | 0.40% | 0.54% | 0.70% | 0.88% | 0.61% | 0.79% | 0.00% |
SNY Sanofi | 5.47% | 4.56% | 4.22% | 3.83% | 4.32% | 3.80% | 3.61% | 3.47% | 4.29% | 3.82% | 4.11% | 3.77% |
Financials
SNY vs. RACE - Financials Comparison
This section allows you to compare key financial metrics between Sanofi and Ferrari N.V.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SNY vs. RACE - Profitability Comparison
SNY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Sanofi reported a gross profit of 8.11B and revenue of 11.24B. Therefore, the gross margin over that period was 72.1%.
RACE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Ferrari N.V. reported a gross profit of 961.64M and revenue of 1.86B. Therefore, the gross margin over that period was 51.8%.
SNY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Sanofi reported an operating income of 2.27B and revenue of 11.24B, resulting in an operating margin of 20.2%.
RACE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Ferrari N.V. reported an operating income of 554.10M and revenue of 1.86B, resulting in an operating margin of 29.9%.
SNY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Sanofi reported a net income of 1.61B and revenue of 11.24B, resulting in a net margin of 14.4%.
RACE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Ferrari N.V. reported a net income of 414.57M and revenue of 1.86B, resulting in a net margin of 22.4%.
Frequently Asked Questions
SNY and RACE have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RACE has higher volatility (12.55%) compared to SNY (8.05%). In terms of maximum drawdown, SNY dropped -46.46% vs RACE's -46.67%.
SNY currently has the higher Sharpe Ratio (-0.32 vs -0.66), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SNY and RACE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer